rct
2009
Effect of Ginkgo biloba versus nifedipine on the frequency of Raynaud attacks: a randomized trial
Choi WS, Choi CJ, Kim KS
Published in Journal of Clinical Pharmacy and Therapeutics
Methodology
Randomised open comparison of Ginkgo biloba extract with nifedipine over 8 weeks in primary Raynaud phenomenon.
Key Findings
Both treatments reduced attack frequency, with nifedipine producing a greater reduction than Ginkgo biloba.
Conclusions
Ginkgo is inferior to standard vasodilator therapy for cold-induced attacks.
Limitations
Small, unblinded, no placebo arm.
Supplements Studied
Ginkgo Biloba
Herb
Both treatments reduced attack frequency, with nifedipine producing a greater reduction than Ginkgo biloba.
Related Health Concerns
Study Details
Year:2009
Sample Size:40
Quality Score:6/10
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.